<p>The figure depicts relationships for (A) <i>P. vivax</i> (n = 141) and (B) <i>P. falciparum</i> (n = 216).</p
<p>Kaplan-Meier plots showing the time to first (or only) (A) <i>P</i>. <i>vivax</i> infection by qP...
<p>Relationship between (i) the total number of reads sequenced in the “<i>P</i>. <i>vivax</i> and a...
<p><b>A. </b><i>P. falciparum</i> viability time-course profiles for chloroquine (chq), mefloquine (...
<p>The figure depicts relationships for (A) <i>P. vivax</i> and (B) <i>P. falciparum</i>.</p
<p>Comparison of the threshold points for amodiaquine, chloroquine and mefloquine, when analysing th...
<p>Threshold modelling results for the relationship between assay duration and estimated CQ EC<sub>5...
<p>Parameter estimates for threshold modelling of the relationship between assay duration and CQ EC<...
<p>Relationship between LM (light microscopy) and PCR determined <i>P. vivax</i> prevalence in 31 cr...
<p>A) Effect of antigenic switch rate on mean infection duration for five values of non-specific ant...
<p><i>P. falciparum</i> viability time-course profiles for artemisinin, atovaquone, GW648495, and GW...
<p>a: distribution of durations of uninterrupted bouts of fever in the malaria therapy data; b: peri...
<p>A) Time course of the parasite infectivity after 0, 4, 8, 24 hours of Blood draw. B) Pvs25 expres...
A Quantification of schizont stage duration in hours and B merozoite number of P. falciparum 3D7 epi...
<p>Correlation between clinical parameters and PS exposure in isolates from DCL (BA276, BA336, BA700...
<p><b>A</b>. <i>P. falciparum</i> viability time-course profiles for atovaquone, pyrimethamine, and ...
<p>Kaplan-Meier plots showing the time to first (or only) (A) <i>P</i>. <i>vivax</i> infection by qP...
<p>Relationship between (i) the total number of reads sequenced in the “<i>P</i>. <i>vivax</i> and a...
<p><b>A. </b><i>P. falciparum</i> viability time-course profiles for chloroquine (chq), mefloquine (...
<p>The figure depicts relationships for (A) <i>P. vivax</i> and (B) <i>P. falciparum</i>.</p
<p>Comparison of the threshold points for amodiaquine, chloroquine and mefloquine, when analysing th...
<p>Threshold modelling results for the relationship between assay duration and estimated CQ EC<sub>5...
<p>Parameter estimates for threshold modelling of the relationship between assay duration and CQ EC<...
<p>Relationship between LM (light microscopy) and PCR determined <i>P. vivax</i> prevalence in 31 cr...
<p>A) Effect of antigenic switch rate on mean infection duration for five values of non-specific ant...
<p><i>P. falciparum</i> viability time-course profiles for artemisinin, atovaquone, GW648495, and GW...
<p>a: distribution of durations of uninterrupted bouts of fever in the malaria therapy data; b: peri...
<p>A) Time course of the parasite infectivity after 0, 4, 8, 24 hours of Blood draw. B) Pvs25 expres...
A Quantification of schizont stage duration in hours and B merozoite number of P. falciparum 3D7 epi...
<p>Correlation between clinical parameters and PS exposure in isolates from DCL (BA276, BA336, BA700...
<p><b>A</b>. <i>P. falciparum</i> viability time-course profiles for atovaquone, pyrimethamine, and ...
<p>Kaplan-Meier plots showing the time to first (or only) (A) <i>P</i>. <i>vivax</i> infection by qP...
<p>Relationship between (i) the total number of reads sequenced in the “<i>P</i>. <i>vivax</i> and a...
<p><b>A. </b><i>P. falciparum</i> viability time-course profiles for chloroquine (chq), mefloquine (...
DOI
Add to ORKG